Eaton Vance Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,284
Closed -$64K 2326
2021
Q4
$64K Sell
1,284
-58
-4% -$3K ﹤0.01% 2009
2021
Q3
$0 Sell
1,342
-394
-23% -$22.2K ﹤0.01% 2396
2021
Q2
$106K Buy
1,736
+1,663
+2,278% +$88.3K ﹤0.01% 1878
2021
Q1
$4K Buy
+73
New +$3.42K ﹤0.01% 2658

Other funds holding LMAT

Eaton Vance Management's LMAT Position: Q1 2022 in Review

Eaton Vance Management sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 1,284 shares — an estimated $64K sold.

Eaton Vance Management first reported a position in LMAT in Q1 2021 and held it in 4 quarters. The position peaked at $106K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Eaton Vance Management reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 1,284 LeMaitre Vascular shares in Q1 2022, an estimated $64K.
  • Eaton Vance Management first reported a position in LeMaitre Vascular in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's LeMaitre Vascular position peaked at $106K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.